Upstream biology
Focus on neuroinflammation, mitochondrial stress, and related pathways rather than a structural imaging readout.
The Blood Biomarkers Test focuses on broader brain-aging biology, using molecular signals linked to neuroinflammation, mitochondrial function, and cellular stress to help you track upstream change over time and receive personalized recommendations.
This product focuses on broader biological aging signals, not Alzheimer's-specific amyloid and tau pathology, with personalized recommendations tied to your biomarker profile.
This product is about broader biological processes that influence brain aging, not a single pathology pathway.
NeuroAge's current FAQ and science materials describe RNA biomarkers as a way to assess how the brain is aging right now, through blood-based signatures linked to neuroinflammation, mitochondrial function, and cellular stress responses.
Because these signals can respond to lifestyle and environmental change, the Blood Biomarkers Test is especially useful for people who want a trackable biological readout and personalized recommendations rather than an inherited-risk or imaging product alone.
Focus on neuroinflammation, mitochondrial stress, and related pathways rather than a structural imaging readout.
Use repeat testing to see whether interventions appear to be shifting the biology you care about.
Pair molecular biology with MRI, NeuroGames, or genetics for broader context when needed.
The Blood Biomarkers Test fits clients who want to measure change in living biology over time.
Use blood-based biology as an objective complement to lifestyle experiments and prevention work.
Start with blood-based insight if you want a lower-friction biological product before imaging.
Repeat testing over time to see whether biological signals appear to be moving.
This page stays intentionally separate from the AD-Detect product.
NeuroAge's FAQ describes RNA biomarkers as blood-based gene-expression patterns that reflect how the brain is aging right now, including signals related to neuroinflammation, mitochondrial function, and cellular stress. Because RNA expression responds to lifestyle and environment, these markers can change over time.
That is what makes this Blood Biomarkers Test different from AD-Detect. The Blood Biomarkers Test is about broader biological aging processes upstream of symptoms, while AD-Detect is specifically centered on Alzheimer's pathology markers such as amyloid and phosphorylated tau.
The dashboard is meant to make repeated blood-based testing easier to review and compare.
See broader biomarker patterns in one place.
Use repeat testing to compare biology over time.
Bring molecular findings into coaching or multimodal planning, with personalized recommendations connected to the pathways your results highlight.

What NeuroAge customers are saying across imaging, testing, and coaching.
NeuroAge's current FAQ describes blood-based biomarker signals linked to broader brain-aging biology, including neuroinflammation, mitochondrial function, and cellular stress responses.
This product focuses on broader biological aging processes. AD-Detect is the more Alzheimer's-specific blood product and emphasizes amyloid and phosphorylated tau pathology markers.
Yes. The Blood Biomarkers Test is especially useful when repeated, because the broader biology it measures may shift with lifestyle, environment, or intervention.
No. It can be used alone, but many people get the clearest picture by combining blood biology with cognition, MRI, genetics, or coaching.
Use a blood-based molecular readout to follow upstream biology, monitor change over time, and act on personalized recommendations.